Profiling the physiological pitfalls of anti‐hepatitis C direct‐acting agents in budding yeast
G Yahya, N Hashem Mohamed, J Pijuan… - Microbial …, 2021 - Wiley Online Library
Sofosbuvir and Daclatasvir are among the direct‐acting antiviral (DAA) medications
prescribed for the treatment of chronic hepatitis C (CHC) virus infection as combination …
prescribed for the treatment of chronic hepatitis C (CHC) virus infection as combination …
Development of diffuse large B‑cell lymphoma after sofosbuvir‑ledipasvir treatment for chronic hepatitis C: A case report and literature review
H Sakai, T Miwa, Y Ikoma, T Hanai… - Molecular and …, 2020 - spandidos-publications.com
Recently, treatments for chronic hepatitis C virus (HCV) infection have significantly improved
by the development of direct‑acting antiviral agents (DAAs) and almost all patients with HCV …
by the development of direct‑acting antiviral agents (DAAs) and almost all patients with HCV …
Acute myeloid leukaemia following direct acting antiviral drugs in HCV-infected patients: A 10 years' retrospective single-center study
C Scheifer, E Luckina, B Lebrun-Vignes… - Clinics and Research in …, 2022 - Elsevier
Background After several cases of peculiar hematological malignancies following
introduction of new oral anti-hepatitis C virus (HCV) treatments in our recent practice, we …
introduction of new oral anti-hepatitis C virus (HCV) treatments in our recent practice, we …
Primary hepatic large B-cell lymphoma following direct-acting antiviral treatment for hepatitis C
Y Zaimi, M Ayari, W Cherifi… - BMJ Open …, 2021 - bmjopengastro.bmj.com
Hepatitis C virus (HCV) infection is a major public health concern worldwide, raising
important medical and economic issues. HCV-related end-stage liver disease is one of the …
important medical and economic issues. HCV-related end-stage liver disease is one of the …
[HTML][HTML] Primary hepatic follicular lymphoma: a case report and literature review
J Xu, S Hu, S Li, Y Gao, W Wang, X Zhou… - … Journal of Clinical …, 2019 - ncbi.nlm.nih.gov
Background: Extranodal lymphomas commonly occur in the spleen, but the likelihood of
primary liver lymphomas is low. As such, studies on the diagnosis and treatment of primary …
primary liver lymphomas is low. As such, studies on the diagnosis and treatment of primary …
Lymphoid Malignancies and Direct-Acting Antivirals
WG Soliman, AM Zaghloul, AM Ali… - The Egyptian Journal …, 2022 - ejhm.journals.ekb.eg
Hepatotropic virus HCV, which can infect hepatocytes, is also lymphotropic and can infect
lymphocytes as well. Epidemiological, clinical, and biological evidence suggests that the …
lymphocytes as well. Epidemiological, clinical, and biological evidence suggests that the …
[PDF][PDF] Transformation of A Marginal Lymphoma in Hepati-tis C Virus-Infected Patient After Clearance of HCV Viral Load
P Martin - Japanese J Gstro Hepato, 2021 - scholar.archive.org
1. Introduction: Previous studies have shown an increased risk of B-cell lymphoproliferative
disorders in patients with chronic hepatitis C virus (HCV) infection, mostly marginal zone …
disorders in patients with chronic hepatitis C virus (HCV) infection, mostly marginal zone …
Direct acting antiviral 治療後に原発不明癌を発症し急激な転機を辿ったC 型肝硬変の1 例
田島和昌， 福嶋伸良， 吉良圭史， 東郷政明， 柴田雅士… - 肝臓, 2022 - jstage.jst.go.jp
抄録 症例は 70 代女性. C 型代償性肝硬変に対し 8 年前に IFN 治療を行ったが副作用で中断. 4
年前に Daclatasvir hydrochloride+ Asunaprevir 投与を行ったが無効. 2 年 4 カ月前から …
年前に Daclatasvir hydrochloride+ Asunaprevir 投与を行ったが無効. 2 年 4 カ月前から …
C 型肝炎に対するdirect-acting antivirals の投与終了直後に, 悪性リンパ腫の再発を認めた1 例
岩根康祐， 萱原隆久， 高畠弘行， 守本洋一… - 日本消化器病学会 …, 2019 - jstage.jst.go.jp
抄録 70 歳代男性. びまん性大細胞型 B 細胞リンパ腫の既往あり, 11 年間無治療で寛解維持し
ていた. 今回 direct-acting antivirals による C 型肝炎治療を行い, SVR を達成. 投与終了直後に …
ていた. 今回 direct-acting antivirals による C 型肝炎治療を行い, SVR を達成. 投与終了直後に …